Contineum Therapeutics, Inc Class A Common Stock
Price & Volume
Stats
See more52W Range | $3.35-$16.33 |
Market Cap | $476.4M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.17 |
News
See moreYahoo Finance • 2 months ago
Cheap high flyer healthcare stocks - high momentum and low valuation
Yahoo Finance • 7 months ago
Contineum Therapeutics Reports Positive Topline Data From PIPE-791 Phase 1b PET Trial
Yahoo Finance • 8 months ago
Contineum Therapeutics Non-GAAP EPS of -$0.62
Yahoo Finance • 10 months ago
Contineum completes enrollment in Phase 1b PET trial cohorts
About
CEO | Mr. Carmine N. Stengone MBA, MS |
Address | 3565 General Atomics Court, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 51 |
